RI
RTW Investments’s Acadia Pharmaceuticals ACAD Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $194M | Buy |
8,995,547
+455,430
| +5% | +$9.82M | 2.76% | 13 |
|
|
2025
Q1 | $142M | Sell |
8,540,117
-165,384
| -2% | -$2.75M | 2.17% | 17 |
|
|
2024
Q4 | $160M | Sell |
8,705,501
-5,002,005
| -36% | -$91.8M | 2.42% | 16 |
|
|
2024
Q3 | $211M | Hold |
13,707,506
| – | – | 3.05% | 12 |
|
|
2024
Q2 | $223M | Sell |
13,707,506
-121,809
| -0.9% | -$1.98M | 3.45% | 11 |
|
|
2024
Q1 | $256M | Buy |
13,829,315
+2,575,764
| +23% | +$47.6M | 3.77% | 7 |
|
|
2023
Q4 | $352M | Sell |
11,253,551
-322,986
| -3% | -$10.1M | 5.5% | 5 |
|
|
2023
Q3 | $241M | Buy |
11,576,537
+1,793,288
| +18% | +$37.4M | 5.09% | 7 |
|
|
2023
Q2 | $234M | Buy |
9,783,249
+1,540,385
| +19% | +$36.9M | 4.46% | 8 |
|
|
2023
Q1 | $155M | Buy |
8,242,864
+4,571,926
| +125% | +$86M | 3.23% | 13 |
|
|
2022
Q4 | $58.4M | Hold |
3,670,938
| – | – | 1.19% | 21 |
|
|
2022
Q3 | $60.1M | Sell |
3,670,938
-553,171
| -13% | -$9.05M | 1.38% | 25 |
|
|
2022
Q2 | $59.5M | Buy |
+4,224,109
| New | +$59.5M | 1.54% | 24 |
|